Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AMPK and mitochondrial complex I refers to the interplay between energy sensing by AMPK and mitochondrial ATP production by complex I. AMPK is commonly activated in states of mitochondrial dysfunction or direct complex I inhibition (e.g., by metformin or rotenone). The interaction of these molecular entities is crucial for cellular adaptation to energetic stress, regulation of mitochondrial quality, and pharmacological intervention in metabolic diseases[2][1][5].
The combined phrase refers to the interplay where AMPK is activated in response to mitochondrial dysfunction or direct complex I inhibition, such as by metformin or rotenone.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMPK and mitochondrial complex I.